Global Heart Catheterization

Heart Catheterization Comprehensive Study by Type (Angiography Catheters, Guiding Catheters, Pulmonary Artery Catheters, PTCA Balloon Catheters, Intravascular Ultrasound (IVUS) Catheters, Electrophysiology Catheters), Application (Diagnosis, Treatment, Monitor, Others), Disease Type (Heart Attack, Abnormal Stress Test, Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centers, Others) Players and Region - Global Market Outlook to 2030

Heart Catheterization Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Heart Catheterization
According to the National Center for Biotechnology Information, U.S., in the United States, more than 1,000,000 cardiac catheterization procedures are performed annually. Heart catheterization is a procedure used to diagnose and treat certain cardiovascular conditions. During this procedure, a long thin tube called a catheter is inserted in an artery or vein in the groin, neck or arm and threaded through blood vessels to the heart. It is also used as part of some procedures to treat heart diseases. This provides information on how well the heart works, identifies problems and allows for procedures to open blocked arteries.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Heart Catheterization market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

St. Jude Medical (United States), Abbott (United States), Johnson & Johnson Private Limited (United States), Boston Scientific Corporation (United States), Coloplast (Denmark), Dispocard GmbH (Germany), Becton, Dickinson and Company (United States), Teleflex Incorporated (United States), Smiths Medical (United States), Edwards Life Sciences Corporation (United States) and Medtronic Inc (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India) and Terumo Medical Corporation (Japan).

Segmentation Overview
AMA Research has segmented the market of Global Heart Catheterization market by Type (Angiography Catheters, Guiding Catheters, Pulmonary Artery Catheters, PTCA Balloon Catheters, Intravascular Ultrasound (IVUS) Catheters and Electrophysiology Catheters), Application (Diagnosis, Treatment, Monitor and Others) and Region.



On the basis of geography, the market of Heart Catheterization has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Type, the sub-segment i.e. Heart Attack will boost the Heart Catheterization market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Heart Catheterization market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Advancement in the Medical Science and Increasing Number of Surgeries Performed around the World

Market Growth Drivers:
Increased Prevalence of Heart Diseases among People in the United States, Increased Number of Hospitals and Clinics and Increasing Number of Regulatory Approvals

Challenges:
Stringent Government Rules and Regulations

Restraints:
Complications Associated with the Procedures and High Cost of Surgical Procedures

Opportunities:
Growth in the Healthcare Industry Worldwide, Increasing Geriatric Population and Increased Research and Development Activities

Market Leaders and their expansionary development strategies
In June 2021, After scoring two FDA clearances last year for medical devices to treat heart and respiratory failure, Abiomed is banking on the old adage that good things come in threes now that it has acquired yet another device for heart failure that’s already well on its way to a regulatory green light.
In March 2022, German-based endovascular simulator specialist CATHI has launched the CATHIS RHC 2, the first in a new generation of Right Heart Catheter (RHC) simulators. Developed in close consultation with the Cologne Cardiovascular Research Center (CCRC) in Germany, the CATHIS RHC 2 offers all the features of CATHI’s original industry-leading RHC simulator, with the additional benefits of wire-assisted navigation and the potential to work with real liquids (S-HUB), thereby allowing thermodilution to be performed on a highly realistic basis.


Key Target Audience
Heart Catheterization Providers, Emerging Companies, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Angiography Catheters
  • Guiding Catheters
  • Pulmonary Artery Catheters
  • PTCA Balloon Catheters
  • Intravascular Ultrasound (IVUS) Catheters
  • Electrophysiology Catheters
By Application
  • Diagnosis
  • Treatment
  • Monitor
  • Others
By Disease Type
  • Heart Attack
  • Abnormal Stress Test
  • Others

By End-users
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Heart Diseases among People in the United States
      • 3.2.2. Increased Number of Hospitals and Clinics
      • 3.2.3. Increasing Number of Regulatory Approvals
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Advancement in the Medical Science
      • 3.4.2. Increasing Number of Surgeries Performed around the World
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Heart Catheterization, by Type, Application, Disease Type, End-users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Heart Catheterization (Value)
      • 5.2.1. Global Heart Catheterization by: Type (Value)
        • 5.2.1.1. Angiography Catheters
        • 5.2.1.2. Guiding Catheters
        • 5.2.1.3. Pulmonary Artery Catheters
        • 5.2.1.4. PTCA Balloon Catheters
        • 5.2.1.5. Intravascular Ultrasound (IVUS) Catheters
        • 5.2.1.6. Electrophysiology Catheters
      • 5.2.2. Global Heart Catheterization by: Application (Value)
        • 5.2.2.1. Diagnosis
        • 5.2.2.2. Treatment
        • 5.2.2.3. Monitor
        • 5.2.2.4. Others
      • 5.2.3. Global Heart Catheterization by: Disease Type (Value)
        • 5.2.3.1. Heart Attack
        • 5.2.3.2. Abnormal Stress Test
        • 5.2.3.3. Others
      • 5.2.4. Global Heart Catheterization by: End-users (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Ambulatory Surgical Centers
        • 5.2.4.4. Others
      • 5.2.5. Global Heart Catheterization Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Heart Catheterization: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. St. Jude Medical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson Private Limited (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Coloplast (Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dispocard GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton, Dickinson and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teleflex Incorporated (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Smiths Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Edwards Life Sciences Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Medtronic Inc (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Heart Catheterization Sale, by Type, Application, Disease Type, End-users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Heart Catheterization (Value)
      • 7.2.1. Global Heart Catheterization by: Type (Value)
        • 7.2.1.1. Angiography Catheters
        • 7.2.1.2. Guiding Catheters
        • 7.2.1.3. Pulmonary Artery Catheters
        • 7.2.1.4. PTCA Balloon Catheters
        • 7.2.1.5. Intravascular Ultrasound (IVUS) Catheters
        • 7.2.1.6. Electrophysiology Catheters
      • 7.2.2. Global Heart Catheterization by: Application (Value)
        • 7.2.2.1. Diagnosis
        • 7.2.2.2. Treatment
        • 7.2.2.3. Monitor
        • 7.2.2.4. Others
      • 7.2.3. Global Heart Catheterization by: Disease Type (Value)
        • 7.2.3.1. Heart Attack
        • 7.2.3.2. Abnormal Stress Test
        • 7.2.3.3. Others
      • 7.2.4. Global Heart Catheterization by: End-users (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Ambulatory Surgical Centers
        • 7.2.4.4. Others
      • 7.2.5. Global Heart Catheterization Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Heart Catheterization: by Type(USD Million)
  • Table 2. Heart Catheterization Angiography Catheters , by Region USD Million (2018-2023)
  • Table 3. Heart Catheterization Guiding Catheters , by Region USD Million (2018-2023)
  • Table 4. Heart Catheterization Pulmonary Artery Catheters , by Region USD Million (2018-2023)
  • Table 5. Heart Catheterization PTCA Balloon Catheters , by Region USD Million (2018-2023)
  • Table 6. Heart Catheterization Intravascular Ultrasound (IVUS) Catheters , by Region USD Million (2018-2023)
  • Table 7. Heart Catheterization Electrophysiology Catheters , by Region USD Million (2018-2023)
  • Table 8. Heart Catheterization: by Application(USD Million)
  • Table 9. Heart Catheterization Diagnosis , by Region USD Million (2018-2023)
  • Table 10. Heart Catheterization Treatment , by Region USD Million (2018-2023)
  • Table 11. Heart Catheterization Monitor , by Region USD Million (2018-2023)
  • Table 12. Heart Catheterization Others , by Region USD Million (2018-2023)
  • Table 13. Heart Catheterization: by Disease Type(USD Million)
  • Table 14. Heart Catheterization Heart Attack , by Region USD Million (2018-2023)
  • Table 15. Heart Catheterization Abnormal Stress Test , by Region USD Million (2018-2023)
  • Table 16. Heart Catheterization Others , by Region USD Million (2018-2023)
  • Table 17. Heart Catheterization: by End-users(USD Million)
  • Table 18. Heart Catheterization Hospitals , by Region USD Million (2018-2023)
  • Table 19. Heart Catheterization Clinics , by Region USD Million (2018-2023)
  • Table 20. Heart Catheterization Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 21. Heart Catheterization Others , by Region USD Million (2018-2023)
  • Table 22. South America Heart Catheterization, by Country USD Million (2018-2023)
  • Table 23. South America Heart Catheterization, by Type USD Million (2018-2023)
  • Table 24. South America Heart Catheterization, by Application USD Million (2018-2023)
  • Table 25. South America Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 26. South America Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 27. Brazil Heart Catheterization, by Type USD Million (2018-2023)
  • Table 28. Brazil Heart Catheterization, by Application USD Million (2018-2023)
  • Table 29. Brazil Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 30. Brazil Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 31. Argentina Heart Catheterization, by Type USD Million (2018-2023)
  • Table 32. Argentina Heart Catheterization, by Application USD Million (2018-2023)
  • Table 33. Argentina Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 34. Argentina Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 35. Rest of South America Heart Catheterization, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Heart Catheterization, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 38. Rest of South America Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 39. Asia Pacific Heart Catheterization, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Heart Catheterization, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Heart Catheterization, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 43. Asia Pacific Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 44. China Heart Catheterization, by Type USD Million (2018-2023)
  • Table 45. China Heart Catheterization, by Application USD Million (2018-2023)
  • Table 46. China Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 47. China Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 48. Japan Heart Catheterization, by Type USD Million (2018-2023)
  • Table 49. Japan Heart Catheterization, by Application USD Million (2018-2023)
  • Table 50. Japan Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 51. Japan Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 52. India Heart Catheterization, by Type USD Million (2018-2023)
  • Table 53. India Heart Catheterization, by Application USD Million (2018-2023)
  • Table 54. India Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 55. India Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 56. South Korea Heart Catheterization, by Type USD Million (2018-2023)
  • Table 57. South Korea Heart Catheterization, by Application USD Million (2018-2023)
  • Table 58. South Korea Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 59. South Korea Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 60. Taiwan Heart Catheterization, by Type USD Million (2018-2023)
  • Table 61. Taiwan Heart Catheterization, by Application USD Million (2018-2023)
  • Table 62. Taiwan Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 63. Taiwan Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 64. Australia Heart Catheterization, by Type USD Million (2018-2023)
  • Table 65. Australia Heart Catheterization, by Application USD Million (2018-2023)
  • Table 66. Australia Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 67. Australia Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Heart Catheterization, by Type USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Heart Catheterization, by Application USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 72. Europe Heart Catheterization, by Country USD Million (2018-2023)
  • Table 73. Europe Heart Catheterization, by Type USD Million (2018-2023)
  • Table 74. Europe Heart Catheterization, by Application USD Million (2018-2023)
  • Table 75. Europe Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 76. Europe Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 77. Germany Heart Catheterization, by Type USD Million (2018-2023)
  • Table 78. Germany Heart Catheterization, by Application USD Million (2018-2023)
  • Table 79. Germany Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 80. Germany Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 81. France Heart Catheterization, by Type USD Million (2018-2023)
  • Table 82. France Heart Catheterization, by Application USD Million (2018-2023)
  • Table 83. France Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 84. France Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 85. Italy Heart Catheterization, by Type USD Million (2018-2023)
  • Table 86. Italy Heart Catheterization, by Application USD Million (2018-2023)
  • Table 87. Italy Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 88. Italy Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 89. United Kingdom Heart Catheterization, by Type USD Million (2018-2023)
  • Table 90. United Kingdom Heart Catheterization, by Application USD Million (2018-2023)
  • Table 91. United Kingdom Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 92. United Kingdom Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 93. Netherlands Heart Catheterization, by Type USD Million (2018-2023)
  • Table 94. Netherlands Heart Catheterization, by Application USD Million (2018-2023)
  • Table 95. Netherlands Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 96. Netherlands Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 97. Rest of Europe Heart Catheterization, by Type USD Million (2018-2023)
  • Table 98. Rest of Europe Heart Catheterization, by Application USD Million (2018-2023)
  • Table 99. Rest of Europe Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 100. Rest of Europe Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 101. MEA Heart Catheterization, by Country USD Million (2018-2023)
  • Table 102. MEA Heart Catheterization, by Type USD Million (2018-2023)
  • Table 103. MEA Heart Catheterization, by Application USD Million (2018-2023)
  • Table 104. MEA Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 105. MEA Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 106. Middle East Heart Catheterization, by Type USD Million (2018-2023)
  • Table 107. Middle East Heart Catheterization, by Application USD Million (2018-2023)
  • Table 108. Middle East Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 109. Middle East Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 110. Africa Heart Catheterization, by Type USD Million (2018-2023)
  • Table 111. Africa Heart Catheterization, by Application USD Million (2018-2023)
  • Table 112. Africa Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 113. Africa Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 114. North America Heart Catheterization, by Country USD Million (2018-2023)
  • Table 115. North America Heart Catheterization, by Type USD Million (2018-2023)
  • Table 116. North America Heart Catheterization, by Application USD Million (2018-2023)
  • Table 117. North America Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 118. North America Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 119. United States Heart Catheterization, by Type USD Million (2018-2023)
  • Table 120. United States Heart Catheterization, by Application USD Million (2018-2023)
  • Table 121. United States Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 122. United States Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 123. Canada Heart Catheterization, by Type USD Million (2018-2023)
  • Table 124. Canada Heart Catheterization, by Application USD Million (2018-2023)
  • Table 125. Canada Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 126. Canada Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 127. Mexico Heart Catheterization, by Type USD Million (2018-2023)
  • Table 128. Mexico Heart Catheterization, by Application USD Million (2018-2023)
  • Table 129. Mexico Heart Catheterization, by Disease Type USD Million (2018-2023)
  • Table 130. Mexico Heart Catheterization, by End-users USD Million (2018-2023)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Heart Catheterization: by Type(USD Million)
  • Table 143. Heart Catheterization Angiography Catheters , by Region USD Million (2025-2030)
  • Table 144. Heart Catheterization Guiding Catheters , by Region USD Million (2025-2030)
  • Table 145. Heart Catheterization Pulmonary Artery Catheters , by Region USD Million (2025-2030)
  • Table 146. Heart Catheterization PTCA Balloon Catheters , by Region USD Million (2025-2030)
  • Table 147. Heart Catheterization Intravascular Ultrasound (IVUS) Catheters , by Region USD Million (2025-2030)
  • Table 148. Heart Catheterization Electrophysiology Catheters , by Region USD Million (2025-2030)
  • Table 149. Heart Catheterization: by Application(USD Million)
  • Table 150. Heart Catheterization Diagnosis , by Region USD Million (2025-2030)
  • Table 151. Heart Catheterization Treatment , by Region USD Million (2025-2030)
  • Table 152. Heart Catheterization Monitor , by Region USD Million (2025-2030)
  • Table 153. Heart Catheterization Others , by Region USD Million (2025-2030)
  • Table 154. Heart Catheterization: by Disease Type(USD Million)
  • Table 155. Heart Catheterization Heart Attack , by Region USD Million (2025-2030)
  • Table 156. Heart Catheterization Abnormal Stress Test , by Region USD Million (2025-2030)
  • Table 157. Heart Catheterization Others , by Region USD Million (2025-2030)
  • Table 158. Heart Catheterization: by End-users(USD Million)
  • Table 159. Heart Catheterization Hospitals , by Region USD Million (2025-2030)
  • Table 160. Heart Catheterization Clinics , by Region USD Million (2025-2030)
  • Table 161. Heart Catheterization Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 162. Heart Catheterization Others , by Region USD Million (2025-2030)
  • Table 163. South America Heart Catheterization, by Country USD Million (2025-2030)
  • Table 164. South America Heart Catheterization, by Type USD Million (2025-2030)
  • Table 165. South America Heart Catheterization, by Application USD Million (2025-2030)
  • Table 166. South America Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 167. South America Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 168. Brazil Heart Catheterization, by Type USD Million (2025-2030)
  • Table 169. Brazil Heart Catheterization, by Application USD Million (2025-2030)
  • Table 170. Brazil Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 171. Brazil Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 172. Argentina Heart Catheterization, by Type USD Million (2025-2030)
  • Table 173. Argentina Heart Catheterization, by Application USD Million (2025-2030)
  • Table 174. Argentina Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 175. Argentina Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 176. Rest of South America Heart Catheterization, by Type USD Million (2025-2030)
  • Table 177. Rest of South America Heart Catheterization, by Application USD Million (2025-2030)
  • Table 178. Rest of South America Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 179. Rest of South America Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 180. Asia Pacific Heart Catheterization, by Country USD Million (2025-2030)
  • Table 181. Asia Pacific Heart Catheterization, by Type USD Million (2025-2030)
  • Table 182. Asia Pacific Heart Catheterization, by Application USD Million (2025-2030)
  • Table 183. Asia Pacific Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 184. Asia Pacific Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 185. China Heart Catheterization, by Type USD Million (2025-2030)
  • Table 186. China Heart Catheterization, by Application USD Million (2025-2030)
  • Table 187. China Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 188. China Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 189. Japan Heart Catheterization, by Type USD Million (2025-2030)
  • Table 190. Japan Heart Catheterization, by Application USD Million (2025-2030)
  • Table 191. Japan Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 192. Japan Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 193. India Heart Catheterization, by Type USD Million (2025-2030)
  • Table 194. India Heart Catheterization, by Application USD Million (2025-2030)
  • Table 195. India Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 196. India Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 197. South Korea Heart Catheterization, by Type USD Million (2025-2030)
  • Table 198. South Korea Heart Catheterization, by Application USD Million (2025-2030)
  • Table 199. South Korea Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 200. South Korea Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 201. Taiwan Heart Catheterization, by Type USD Million (2025-2030)
  • Table 202. Taiwan Heart Catheterization, by Application USD Million (2025-2030)
  • Table 203. Taiwan Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 204. Taiwan Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 205. Australia Heart Catheterization, by Type USD Million (2025-2030)
  • Table 206. Australia Heart Catheterization, by Application USD Million (2025-2030)
  • Table 207. Australia Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 208. Australia Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Heart Catheterization, by Type USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Heart Catheterization, by Application USD Million (2025-2030)
  • Table 211. Rest of Asia-Pacific Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 212. Rest of Asia-Pacific Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 213. Europe Heart Catheterization, by Country USD Million (2025-2030)
  • Table 214. Europe Heart Catheterization, by Type USD Million (2025-2030)
  • Table 215. Europe Heart Catheterization, by Application USD Million (2025-2030)
  • Table 216. Europe Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 217. Europe Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 218. Germany Heart Catheterization, by Type USD Million (2025-2030)
  • Table 219. Germany Heart Catheterization, by Application USD Million (2025-2030)
  • Table 220. Germany Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 221. Germany Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 222. France Heart Catheterization, by Type USD Million (2025-2030)
  • Table 223. France Heart Catheterization, by Application USD Million (2025-2030)
  • Table 224. France Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 225. France Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 226. Italy Heart Catheterization, by Type USD Million (2025-2030)
  • Table 227. Italy Heart Catheterization, by Application USD Million (2025-2030)
  • Table 228. Italy Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 229. Italy Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 230. United Kingdom Heart Catheterization, by Type USD Million (2025-2030)
  • Table 231. United Kingdom Heart Catheterization, by Application USD Million (2025-2030)
  • Table 232. United Kingdom Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 233. United Kingdom Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 234. Netherlands Heart Catheterization, by Type USD Million (2025-2030)
  • Table 235. Netherlands Heart Catheterization, by Application USD Million (2025-2030)
  • Table 236. Netherlands Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 237. Netherlands Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 238. Rest of Europe Heart Catheterization, by Type USD Million (2025-2030)
  • Table 239. Rest of Europe Heart Catheterization, by Application USD Million (2025-2030)
  • Table 240. Rest of Europe Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 241. Rest of Europe Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 242. MEA Heart Catheterization, by Country USD Million (2025-2030)
  • Table 243. MEA Heart Catheterization, by Type USD Million (2025-2030)
  • Table 244. MEA Heart Catheterization, by Application USD Million (2025-2030)
  • Table 245. MEA Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 246. MEA Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 247. Middle East Heart Catheterization, by Type USD Million (2025-2030)
  • Table 248. Middle East Heart Catheterization, by Application USD Million (2025-2030)
  • Table 249. Middle East Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 250. Middle East Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 251. Africa Heart Catheterization, by Type USD Million (2025-2030)
  • Table 252. Africa Heart Catheterization, by Application USD Million (2025-2030)
  • Table 253. Africa Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 254. Africa Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 255. North America Heart Catheterization, by Country USD Million (2025-2030)
  • Table 256. North America Heart Catheterization, by Type USD Million (2025-2030)
  • Table 257. North America Heart Catheterization, by Application USD Million (2025-2030)
  • Table 258. North America Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 259. North America Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 260. United States Heart Catheterization, by Type USD Million (2025-2030)
  • Table 261. United States Heart Catheterization, by Application USD Million (2025-2030)
  • Table 262. United States Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 263. United States Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 264. Canada Heart Catheterization, by Type USD Million (2025-2030)
  • Table 265. Canada Heart Catheterization, by Application USD Million (2025-2030)
  • Table 266. Canada Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 267. Canada Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 268. Mexico Heart Catheterization, by Type USD Million (2025-2030)
  • Table 269. Mexico Heart Catheterization, by Application USD Million (2025-2030)
  • Table 270. Mexico Heart Catheterization, by Disease Type USD Million (2025-2030)
  • Table 271. Mexico Heart Catheterization, by End-users USD Million (2025-2030)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Heart Catheterization: by Type USD Million (2018-2023)
  • Figure 5. Global Heart Catheterization: by Application USD Million (2018-2023)
  • Figure 6. Global Heart Catheterization: by Disease Type USD Million (2018-2023)
  • Figure 7. Global Heart Catheterization: by End-users USD Million (2018-2023)
  • Figure 8. South America Heart Catheterization Share (%), by Country
  • Figure 9. Asia Pacific Heart Catheterization Share (%), by Country
  • Figure 10. Europe Heart Catheterization Share (%), by Country
  • Figure 11. MEA Heart Catheterization Share (%), by Country
  • Figure 12. North America Heart Catheterization Share (%), by Country
  • Figure 13. Global Heart Catheterization share by Players 2023 (%)
  • Figure 14. Global Heart Catheterization share by Players (Top 3) 2023(%)
  • Figure 15. Global Heart Catheterization share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. St. Jude Medical (United States) Revenue, Net Income and Gross profit
  • Figure 18. St. Jude Medical (United States) Revenue: by Geography 2023
  • Figure 19. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott (United States) Revenue: by Geography 2023
  • Figure 21. Johnson & Johnson Private Limited (United States) Revenue, Net Income and Gross profit
  • Figure 22. Johnson & Johnson Private Limited (United States) Revenue: by Geography 2023
  • Figure 23. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 25. Coloplast (Denmark) Revenue, Net Income and Gross profit
  • Figure 26. Coloplast (Denmark) Revenue: by Geography 2023
  • Figure 27. Dispocard GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Dispocard GmbH (Germany) Revenue: by Geography 2023
  • Figure 29. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 30. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 31. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 32. Teleflex Incorporated (United States) Revenue: by Geography 2023
  • Figure 33. Smiths Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Smiths Medical (United States) Revenue: by Geography 2023
  • Figure 35. Edwards Life Sciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Edwards Life Sciences Corporation (United States) Revenue: by Geography 2023
  • Figure 37. Medtronic Inc (United States) Revenue, Net Income and Gross profit
  • Figure 38. Medtronic Inc (United States) Revenue: by Geography 2023
  • Figure 39. Global Heart Catheterization: by Type USD Million (2025-2030)
  • Figure 40. Global Heart Catheterization: by Application USD Million (2025-2030)
  • Figure 41. Global Heart Catheterization: by Disease Type USD Million (2025-2030)
  • Figure 42. Global Heart Catheterization: by End-users USD Million (2025-2030)
  • Figure 43. South America Heart Catheterization Share (%), by Country
  • Figure 44. Asia Pacific Heart Catheterization Share (%), by Country
  • Figure 45. Europe Heart Catheterization Share (%), by Country
  • Figure 46. MEA Heart Catheterization Share (%), by Country
  • Figure 47. North America Heart Catheterization Share (%), by Country
List of companies from research coverage that are profiled in the study
  • St. Jude Medical (United States)
  • Abbott (United States)
  • Johnson & Johnson Private Limited (United States)
  • Boston Scientific Corporation (United States)
  • Coloplast (Denmark)
  • Dispocard GmbH (Germany)
  • Becton, Dickinson and Company (United States)
  • Teleflex Incorporated (United States)
  • Smiths Medical (United States)
  • Edwards Life Sciences Corporation (United States)
  • Medtronic Inc (United States)
Additional players considered in the study are as follows:
Rochester Medical Corporation (U.S) , Maquet Medical India Private Limited (India) , Terumo Medical Corporation (Japan)
Select User Access Type

Key Highlights of Report


Mar 2024 240 Pages 65 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Heart Catheterization Quantitative research analysis
Global Heart Catheterization Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as St. Jude Medical (United States), Abbott (United States), Johnson & Johnson Private Limited (United States), Boston Scientific Corporation (United States), Coloplast (Denmark), Dispocard GmbH (Germany), Becton, Dickinson and Company (United States), Teleflex Incorporated (United States), Smiths Medical (United States), Edwards Life Sciences Corporation (United States) and Medtronic Inc (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Advancement in the Medical Science " is seen as one of major influencing trends for Heart Catheterization Market during projected period 2023-2030.
The Heart Catheterization market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Heart Catheterization Report?

Have a Query? Click Here

Other Related Reports

Blood Pressure Monitoring Devices Comprehensive Study by Type (Sphygmomanometers, Automated BP Monitors, Ambulatory BP Monitors, BP Transducers, BP Instruments Accessories), Application (Hospital, Cl...
$ 3650
Interventional Neurology Device Comprehensive Study by Application (Oncology, Cardiology, Urology & Nephrology), Indication (Cerebral Aneurysms, Ischemic Stroke, Arteriovenous Malformations, Others),...
$ 3750
Ear Speculum Comprehensive Study by Type (Plastic, Stainless Steel, Others), Application (Surgery, Examination, Others), Usage (Disposable, Non-Disposable), Size (0.5 to 3mm, 4 to 6 mm, Above 7mm) Pl...
$ 3500
Intraoral Scanners Comprehensive Study by Type (Standalone Intraoral Scanners, Portable Intraoral Scanners), End User (Hospitals, Dental Clinics, Others) Players and Region - Global Market Outlook to...
$ 3500
Medical Silicone Comprehensive Study by Type (Liquid Silicone Rubber, High Consistency Rubber, Fluorosilicone Rubber, Room Temperature Vulcanize Silicone), Application (Prosthetics (limbs & implants)...
$ 3650
Bandage Roll Comprehensive Study by Type (Sterile Bandage, Non-Sterile Bandage), Application (Hospital & Clinical, Home Care, Other), Bandage Roll Type (General, Waterproof), Use (Wound Dressing, Sur...
$ 3450